A 2013 European survey of clinical practice patterns in the management of Graves' disease
- 9 January 2015
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 84 (1), 115-120
- https://doi.org/10.1111/cen.12688
Abstract
Objective Management of Graves' disease (GD) in Europe was published in 1987. Aim of this survey was to provide an update on clinical practice in Europe, and to compare it with a 2011 American survey. Design Members of the European Thyroid Association (ETA) were asked to participate in a survey on management of GD, using the same questionnaire of a recent American survey. Results A total of 147 ETA members participated. In addition to serum TSH and free T4 assays, most respondents would request TSH-receptor autoantibody (TRAb) measurement (85.6%) and thyroid ultrasound (70.6%) to confirm aetiology, while isotopic studies were selected by 37.7%. Antithyroid drug (ATD) therapy was the preferred first-line treatment (83.8%). Compared to the previous European survey, Europeans currently more frequently use TRAb measurement and thyroid ultrasound for diagnosis and evaluation, but first-line treatment remains ATDs in a similar percentage of respondents. Current clinical practice patterns differ from those in North America, where isotopic studies are more frequently used, and radioiodine (RAI) still is first-line treatment. When RAI treatment is selected in the presence of mild Graves' orbitopathy and/or associated risk factors for its occurrence/exacerbation, steroid prophylaxis is frequently used. The preferred ATD in pregnancy is propylthiouracil in the first trimester and methimazole in the second and third trimesters, similar to North America. Conclusions Significant changes in clinical practice patterns in Europe were noted compared to the previous European survey, as well as persisting differences in diagnosis and therapy between Europe and North America.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (2012Z3F7HE)
This publication has 33 references indexed in Scilit:
- Analytical Performance and Clinical Utility of a Bioassay for Thyroid-Stimulating ImmunoglobulinsAmerican Journal of Clinical Pathology, 2013
- TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysisAutoimmunity Reviews, 2012
- Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and PostpartumThyroid®, 2011
- The American Thyroid Association/American Association of Clinical Endocrinologists Guidelines for Hyperthyroidism and Other Causes of Thyrotoxicosis: A European PerspectiveThyroid®, 2011
- The American Thyroid Association and American Association of Clinical Endocrinologists Hyperthyroidism and Other Causes of Thyrotoxicosis Guidelines: Viewpoints from Japan and KoreaThyroid®, 2011
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical EndocrinologistsThyroid®, 2011
- Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulinsClinical and Experimental Immunology, 2010
- A Novel Bioreporter Assay for Thyrotropin Receptor Antibodies Using a Chimeric Thyrotropin Receptor (Mc4) Is More Useful in Differentiation of Graves' Disease from Painless Thyroiditis Than Conventional Thyrotropin-Stimulating Antibody Assay Using Porcine Thyroid CellsThyroid®, 2010
- Shifts in Propylthiouracil and Methimazole Prescribing Practices: Antithyroid Drug Use in the United States from 1991 to 2008Journal of Clinical Endocrinology & Metabolism, 2010
- Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease (GD): an international multicentre trialClinical Endocrinology, 2009